In the MILES-@ study patients with non-squamous histology are randomized , in a factorial design with @ ratio , to four arms : gemcitabine ( A ) , cisplatin/gemcitabine ( B ) , pemetrexed ( C ) , cisplatin/pemetrexed ( D ) .